USANA Health Sciences Inc
SWB:USJ

Watchlist Manager
USANA Health Sciences Inc Logo
USANA Health Sciences Inc
SWB:USJ
Watchlist
Price: 17.4 EUR -2.25%
Market Cap: €670.9m

USANA Health Sciences Inc
Investor Relations

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,978 full-time employees. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 23, 2025
AI Summary
Q3 2025

Sales Activity: USANA saw a recent pickup in sales activity and leader productivity following a slow start to Q3, especially after its Global Convention in August.

Compensation Plan Rollout: The global rollout of an enhanced compensation plan is showing early promising results, particularly in mature markets like the US, with increased engagement and faster earnings for Brand Partners.

Venture Growth: Hiya achieved 26% year-to-date sales growth, while Rise Bar posted record quarterly sales, up 169% year-to-date, contributing to portfolio diversification.

Cost Reduction: USANA initiated a global cost reduction process, including workforce rightsizing, expecting a $4.7 million onetime charge in Q4.

Industry Conditions: Management acknowledged ongoing challenges in the direct selling and vitamin markets due to competition and shifting consumer demands, but remains confident in their strategy and the value proposition.

Guidance and Outlook: Hiya is expected to deliver double-digit sales growth in 2025, and management will provide more details on cost savings and strategic initiatives in February.

Key Financials
Hiya Sales Growth (YTD)
26%
Rise Bar Net Sales Growth (YTD)
169%
Cost Reduction Charge (Q4)
$4.7 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Kevin G. Guest
Executive Chairman
No Bio Available
Mr. Jim Brown
CEO & President
No Bio Available
Mr. G. Douglas Hekking
Chief Financial Officer
No Bio Available
Mr. Walter Noot
Chief Operating Officer
No Bio Available
Mr. P. Joshua Foukas J.D.
Chief Legal Officer, General Counsel & Corporate Secretary
No Bio Available
Mr. Daniel A. Macuga Jr.
Chief Communications & Marketing Officer
No Bio Available
Dr. Myron W. Wentz Ph.D.
Founder & Chairman Emeritus
No Bio Available
Dr. John Cuomo
Executive Director of Product Development & Technology
No Bio Available
Dr. Robert A. Sinnott M.N.S., Ph.D.
Chief Scientific Officer
No Bio Available
Peter Benedict
Chief Information Officer
No Bio Available

Contacts

Address
UTAH
Salt Lake City
3838 W Parkway Blvd
Contacts
+18019547100.0
www.usana.com